Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02712723
Title Letrozole Plus Ribociclib or Placebo as Neo-adjuvant Therapy in ER-positive, HER2-negative Early Breast Cancer (FELINE)
Acronym FELINE
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Qamar Khan
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences Little Rock Arkansas 72205 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
Cancer Research Collaboration Santa Ana California 92705 United States Details
University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach Florida 33442 United States Details
University of Kansas Cancer Center - West Kansas City Kansas 66112 United States Details
University of Kansas Cancer Center - Overland Park Overland Park Kansas 66210 United States Details
University of Kansas Cancer Center - Westwood Westwood Kansas 66205 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Kansas Cancer Center - South Kansas City Missouri 64131 United States Details
University of Kansas Cancer Center - North Kansas City Missouri 64154 United States Details
University of Kansas Cancer Center - Lee's Summit Lee's Summit Missouri 64064 United States Details
Columbia University Medical Center New York New York 10032 United States Details
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field